Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,170 | -1,858 | -1,824 | 15,347 | -3,110 |
| Depreciation Amortization | 196 | 133 | 66 | 452 | 140 |
| Accounts receivable | N/A | N/A | N/A | -353 | N/A |
| Accounts payable and accrued liabilities | -1,211 | -1,241 | -531 | -1,408 | N/A |
| Other Working Capital | -2,947 | -1,896 | -383 | -1,834 | 860 |
| Other Operating Activity | -5,519 | -2,533 | -1,109 | -1,041 | 1,260 |
| Operating Cash Flow | $-12,651 | $-7,395 | $-3,781 | $11,163 | $-850 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -111,773 | -834 | 23,374 | 80,236 | N/A |
| Investing Cash Flow | $-111,773 | $-834 | $23,374 | $80,236 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 435 | 271 | 39 | 1,101 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -26,207 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 298 | 860 |
| Financing Cash Flow | $435 | $271 | $39 | $-24,808 | $860 |
| Beginning Cash Position | 153,158 | 153,158 | 153,158 | 86,567 | 0 |
| End Cash Position | 29,169 | 145,200 | 172,790 | 153,158 | 10 |
| Net Cash Flow | $-123,989 | $-7,958 | $19,632 | $66,591 | $10 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,651 | -7,395 | -3,781 | 11,163 | -850 |
| Free Cash Flow | -12,651 | -7,395 | -3,781 | 11,163 | -850 |